JEFO Keesler_FINAL_Redacted.pdf
PDF 327 KB Posted
- Attached to
- JEFO
- Solicitation number
- SPE2D1-26-F-0155
About this file
This is a Justification for an Exception to Fair Opportunity (JEFO) document submitted by the Defense Logistics Agency (DLA) Troop Support, Medical Supply Chain, Capital Equipment Division for a single-source acquisition.
The document justifies an order for one BK3000 ultra-high resolution ultrasound system for the United States Air Force Medical Center Keesler under BK Medical Holding Company, Inc.'s Long-Term Contract (LTC) SPE2D1-19-D-0023, which expires June 12, 2029. The JEFO invokes the authority of FAR 16.507-6(b)(2) as implemented by DOD Class Deviation 2026-O0045, citing that only one awardee is capable of providing supplies meeting the required specifications at the necessary quality level. The ultrasound system must provide ultra-high-resolution capabilities for urological, OB/GYN, and cancer detection diagnosis with specific clinical features including Tissue Harmonic Imaging, Real Time Tissue Elastography, and Strain Histogram Measurement. Additional mandatory requirements include tri-plane transducers for three-dimensional visualization without changing transducers, at least three active transducer ports, dual biopsy guides for biplane and endfire biopsies, and system software supporting intra-cavity scanning, general ultrasonic examinations, intra-operative procedures with advanced MRI/CT image fusion, and biopsy precision enhancement. Market research conducted in March 2026 confirmed that BK Medical Holding Company, Inc.'s bk3000 system is the only product on a DLA contract meeting all minimum requirements, as competing vendors Canon, Fujifilm, and Philips could not provide tri-plane transducers for the required applications. The contracting officer certified the justification as accurate and complete on May 11, 2026.
View the file
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Page | 1
JUSTIFICATION FOR AN EXCEPTION TO FAIR OPPORTUNITY (JEFO)
BK MEDICAL HOLDING COMPANY, INC.
SOLICITATION: SPE2D1-15-R-0001
CONTRACT: SPE2D1-19-D-0023
BK MEDICAL HOLDING COMPANY, INC.
(1) Defense Logistics Agency (DLA) Troop Support, Medical Supply Chain, Capital Equipment
Division, is the contracting activity.
(2) The action submitted for approval is a JEFO supporting the acquisition of one (1) bk3000 ultra-high resolution ultrasound system as required by United States Air Force (USAF) Medical Center Keesler. In support of this acquisition, the order will be placed under BK Medical Holding Company, Inc.’s basic Long-Term Contract (LTC) SPE2D1-19-D-0023, which expires 12 June 2029. This JEFO will allow an order to be placed without following the fair opportunity process.
(3) The total estimated dollar value of this action is
(4) The authority waiving the competition requirements is FAR 16.507-6(b)(2) (as implemented by
DOD Class Deviation 2026-O0045 (MAR 2026)), only one awardee is capable of providing the supplies or services required at the level of quality required because the supplies or services ordered are unique or highly specialized.
The required ultrasound system must meet the following minimum requirements established by USAF Medical Center Keesler:
a. Must provide an ultra-high-resolution ultrasound system for Urological, OB/GYN and cancer detection diagnosis, including specific clinical capabilities as Tissue Harmonic Imagining (THI), Real Time Tissue Elastography (RTE), and Strain Histogram Measurement
b. Must have tri-plane transducers allowing for three-dimensional visualization of anatomy without changing the transducers during an intra-cavity examination/treatment
c. Must have at least three (3) active transducer ports
d. Must provide dual biopsy guides that allow for biplane and endfire biopsies without changing the transducer
e. Must have system software that can meet specific clinical needs, such as intra-cavity scanning, general ultrasonic examinations, intra-operative procedures with advanced MRI/CT image fusion, and enhancing biopsy precision
(5) Market research was performed in March 2026 assessing whether other vendors could provide an ultrasound system that meets all the minimum requirements of the facility. Market research findings
File details come from the government source that posted it. Updated .